Switzerland Mulls Discounts On Top-Selling Drugs To Cut Health Costs

2026-02-19 02:08:56

(MENAFN- Swissinfo) The Swiss parliament is considering limiting the steady rise of healthcare costs by granting discounts on best-selling medicines in the country. The government is now submitting this measure to a consultation process. Select your language

Generated with artificial intelligence. Listening: Switzerland mulls discounts on top-selling drugs to cut health costs This content was published on February 19, 2026 - 14:17 2 minutes Keystone-SDA

Français fr Les médicaments les plus vendus au rabais pour baisser les primes Original Read more: Les médicaments les plus vendus au rabais pour baisser les p

+ Get the most important news from Switzerland in your inbox

Last year, the federal parliament approved a package of measures designed to reduce healthcare costs, including quantity discounts. On Thursday, the government announced that it had opened the consultation procedure on legal amendments to introduce these measures.

Of the more than 3,000 products on a national list of medicines approved for coverage under basic health insurance, the 80-100 best-selling drugs generate more than a third of the costs of all these medicines combined. This corresponds to CHF3 billion ($3.87 billion), according to the government.
More More How drug prices are negotiated in Switzerland and beyond
This content was published on Apr 23, 2024 Switzerland's pharmaceutical sector supplies drugs worldwide, but not all countries receive them with the same price tag. Here's why.
Read more: How drug prices are negotiated in Switzerland and b

MENAFN19022026000210011054ID1110764718

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.